Vericel Corporation

47.40 USD
+0.08 (+0.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vericel Corporation stock is up 11.27% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 9 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Feb 20:24 15 Mar, 2024 50.00 CALL 217 188
16 Feb 19:41 16 Feb, 2024 45.00 CALL 388 430

About Vericel Corporation

Vericel Corporation engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee. Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal. NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-th thickness.